Teva to Acquire Chinese Biogenerics Manufacturer  

Oleh:

Kats-Nelson, Alla

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Nature Biotechnology: The Science and Business of Biotechnology vol. 23 no. 7 (Jul. 2005), page 765.
Topik: MANUFACTURE; teva; chinese biogenerics manufacturer

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: NN9.3 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

With follow on biologics in the united states still stuck in regulatory purgatory, israeli generics giant teva pharmaceuticals is forging ahead in biogenerics throuh a chinese acquisition. By tackling less strictly regulated markets first, teva could gain more experience in manufacturing biogenerics and profit from those markets directly. But skeptics point out that the gap in approval standards between china and western countries is no guarantee of an easier entry into the more lucrative european and US markets...

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali